The strain Enterncoccus faeciurn T I 36 produces two bacteriocins, enterocin A, a member of the pediocin family of bacteriocins, and a new bacteriocin termed enterocin B. The N-terminal amino acid sequences of enterocins A and B were determined, and the gene encoding enterocin B was sequenced. The primary translation product was a 71 aa peptide containing a leader peptide of the double-glycine type which is cleaved off to give mature enterocin B of 53 aa. Enterocin B does not belong to the pediocin family of bacteriocins and shows strong homology to carnobacteriocin A. However, sequence similarities in their leader peptides and C-termini suggest that enterocin B and carnobacteriocin A are related to bacteriocins of the pediocin family. Enterocins A and B had only slightly different inhibitory spectra, and both were active against a wide range of Gram-positive bacteria, including listeriae, staphylococci and most lactic acid bacteria tested. Both had bactericidal activities, but survival at a frequency of 10-4-10-2 was observed when sensitive cultures were exposed to either bacteriocin. The number of survivors was drastically reduced when a mixture of the two bacteriocins was added to the cells.
INTRODUCTION
Bacteriocins are antimicrobial proteins or peptides that are usually inhibitory only to strains closely related to the producing bacteria. Many bacteriocins from Grampositive bacteria have fairly broad inhibitory spectra, and these bacteriocins may therefore have an applied potential as antimicrobial agents. In particular, bacteriocins from lactic acid bacteria have become attractive as natural food preservatives. Lactic acid bacteria have been used in food and feed preservation for centuries, and their preservative effects are mainly due to the formation of large amounts of lactic acid. This is not always sufficient to prevent bacterial spoilage or outgrowth of pathogenic bacteria, but bacteriocinproducing lactic acid bacteria may serve as a replacement for chemical preservatives in foods (Daeschel, 1989) . The broad spectrum bacteriocins from lactic acid bacteria that have been characterized are all small (2-5-6 kDa), heat stable, hydrophobic and cationic . 
The GenBank accession number for the nucleotide sequence reported in this paper is U87997. peptides (Klaenhammer, 1993) . The best studied is nisin, which is produced by strains of Lactococcus lactis (Gross & Morell, 1971) . This bacteriocin is approved as a food additive in many countries, and its efficiency in preventing the growth of spoilage bacteria has been proven in a number of food systems (Delves-Broughton, 1990) . Another commercial bacteriocin is pediocin PA-1, produced by Pediococcus acidilactici PAC 1.0 (Gonzalez & Kunka, 1987) . This bacteriocin does not have as broad an inhibitory spectrum as nisin but it is very active against the food-borne pathogen Listeria monocytogenes, which is usually not very sensitive to nisin (Benkerroum & Sandine, 1988; de Vos et al., 1993) . Pediocin PA-1 belongs to the pediocin family of bacteriocins, identified by conserved amino acid sequences particularly in the N-terminal part of the molecule. Bacteriocins belonging to this family are produced by several genera of lactic acid bacteria, and they are all very active against listeriae (Lozano et al., 1992 ; Aymerich et al., 1996) .
Application studies have, however, shown that there are limitations to the usefulness of bacteriocins as antimicrobial agents. Nisin is unstable at pH >5, and IP: 54.70. 40.11 On: Fri, 07 Dec 2018 05:36:16 P. CASAUS a n d OTHERS although bacteriocins of the pediocin family are able to extend the shelf-life of food products, full suppression of the spoilage microflora is rarely achieved (Pucci et al., 1988; Schillinger et al., 1991) . Most of the bacteriocins that have been studied appear to inhibit the target cells by causing permeabilization of the cell membrane. For non-lantibiotic bacteriocins such as lactococcin A a n d pediocin PA-1, the involvement of specific membranebound receptors has been inferred from the findings that liposomes are not affected (van Belkum et Chikindas et al., 1993) . Complete elucidation of the primary structure of the various bacteriocins can give insight into structure-function relationships and possibly enable us to construct even more efficient bacteriocins.
In this work, we describe enterocin B. This is a new bacteriocin with a broad spectrum of inhibition that acts synergistically with enterocin A, a member of the pediocin family.
METHODS
Isolation and characterization of the bacteriocin-producing strain. Lactic acid bacteria were isolated from Spanish dryfermented sausages, manufactured with no added starter cultures, and screened for antimicrobial activity using Lactobacillus sake FVM 148 and List. monocytogenes Scott A as indicators as described previously (Cintas et al., 1995) . The isolate T136 was selected for further studies because of its strong inhibitory activity against both these indicators. The strain was examined according to Schleifer & Kilpper-Balz (1984) and further tested for arginine dihydrolase activity, Voges-Proskauer reaction (acetoin production), growth on media containing 0.04% sodium azide (Bacto E V A broth; Oxoid), urease activity and haemolysis on 5 '/o calf-blood agar plates (Oxoid) as proposed by Devriese et al. (1993) . Fermentation patterns were determined with API Rapid CH fermentation strips (BioMkrieux). Total proteins were analysed by SDS-PAGE and the pattern obtained was compared with those of reference strains described by Kersters & de Ley (1975) and Pot et al. (1994) by B. Pot, University of Ghent, Belgium.
Purification of enterocins A and B.
Enterocins A and B were purified from a 21 culture of Enterococcus faecium T136 grown for 18 h in MRS broth (Difco) at 30 "C in a fermenter kept at pH 5.7 by the addition of 6 M sodium hydroxide. The cells were removed by centrifugation and 40 g Amberlite XAD-16 (Supelco) was added to the supernatant. The matrix was washed and the bacteriocin activity was eluted as described by Hiivarstein et al. (1994) . The eluate was subjected to cation-exchange chromatography followed by hydrophobic interaction chromatography and reverse-phase chromatography as described by Aymerich et al. (1996) .
Amino acid sequencing. The N-terminal amino acid sequences were determined by Edman degradation with an Applied Biosystems 477A automatic sequencer with an on-line 120A phenylthiohydantoin amino acid analyser, as described previously by Cornwell et al. (1988) . Mass spectrometry. Determination of the molecular mass of enterocin B was performed at the Institut fur Organisch Chemie, Eberhard-Karls-Universitat Tubingen, Germany, with an electrospray-ionizing mass spectrometer, API I11 TAGA 6000E (CIEX). Bacteriocin assays. Bacteriocin activity was quantified using the microtitre plate assay (Holo et al., 1991) . Each well in the microtitre plate contained in 200pl MRS broth (pH 6-5) bacteriocin fractions at twofold dilution and the indicator organism (lo4 times dilution of an overnight culture). The microtitre plate cultures were incubated overnight (16-20 h) at 30 "C, after which growth inhibition of the indicator organism was measured spectrophotometrically at 600 nm by using a Dynatech Microplate Reader. One bacteriocin unit was defined as the amount of bacteriocin causing 50 '/o growth inhibition (50 ' / o of the turbidity of the control culture without bacteriocin) in this assay. Minimal inhibitory concentration (MIC) values were determined using the method described by Cintas et al. (1995) . Concentrations of purified enterocin A and enterocin B were determined spectrophotometrically at 280 nm. The bactericidal effects of enterocin A and enterocin B were studied by the following assay. Overnight cultures of Enterococcus faecalis EF and Lact. sake NCDO 2714 were diluted 100 times in MRS. Bacteriocin was added and the cultures were incubated at 30°C. Viable counts were determined by plating on MRS agar plates.
PCR and DNA sequencing. DNA was isolated from E. faecium T136 by the method of Anderson & McKay (1983) . Restriction enzymes and other DNA modifying enzymes were used as recommended by the manufacturers. The sequence of the entB gene was determined by sequencing PCR products obtained with the primers shown in Table 1 . Amplification reactions were carried out with the Gene Amp PCR kit in a DNA thermal cycler according to the supplier's (Perkin Elmer Cetus) instructions. PCR products were purified by agarose gel electrophoresis and extracted with the Qiaex I1 gel extraction kit (Qiagen). Primers ENTBl and ENTB2 (see Table 1 ) were used in PCR to amplify a 92 bp fragment which was treated with the Klenow fragment of DNA polymerase I to generate blunt ends. Other blunt-ended DNA fragments were obtained by digesting E. faecium T136 DNA with DraI, HincII and SspI. They were all ligated to plasmid vector Bluescript SK I1 Enterocins A and B
(Stratagene) cut with HincII. The ligation mixtures served as templates for the generation of biotinylated PCR products using entB-specific primers in combination with the biotinylated SK2 primer. Single-stranded DNA for DNA sequencing was obtained with the Dynabead M-280 Streptavidin kit and the magnetic separator Dynal-MPC-El. The Sequenase 2.0 system (USB) was used in the sequence reactions. Analyses of DNA and protein sequences were performed using the Sequence Analysis Software Package (version 8) (Devereux et al., 1984) licensed from the Genetics Computer Group, University of Wisconsin, Madison, USA.
RESULTS

Identification of E. faecium TI36
The enterocins A and B producing isolate T136 described in this work was identified as E . faecium by the following criteria (Devriese et al., 1993) : a catalasenegative, Gram-positive, facultatively anaerobic coccus with the ability to grow at 10 and 45 "C in media containing 6-5 % NaCl, at p H 9.6, and in the presence of both 40 % (v/v) bile and 0-04 % sodium azide. It did not produce gas from glucose, gave a positive Voges-Proskauer reaction and produced ammonia from arginine. The final pH in glucose broth was 4.4, and acid was produced from ribose and L-arabinose, but not from glycogen, D-arabitol, sorbitol or gluconate. The strain did not show urease activity and it was nonhaemolytic on calf-blood agar. This identification was supported by comparison of its SDS-PAGE protein pattern with a database of protein patterns from lactic acid bacteria according to Kersters & de Ley (1975) and Pot et al. (1994) .
Characterization of enterocins A and B
The supernatant from a culture grown in a fermenter at pH5.7 was used for the isolation of the antimicrobial compounds. The last step in the purification procedure ( Table 2) , reverse-phase chromatography, revealed two well-separated bacteriocin activities.
By rechromatography on the reverse-phase column, both were purified to homogeneity. Amino acid sequ- encing combined with PCR analysis showed that one of the two bacteriocins was identical to enterocin A described previously (Aymerich et al., 1996) , while the other was a new bacteriocin, which we have termed enterocin B. By amino acid sequencing we obtained the following sequence: ENDHRMPNELNRPNxLSKGG-AKxGAAIAGGLFGIPKGxLAW-. The molecular mass of enterocin B was determined as 5479*0_+ 1.2 Da by mass spectrometry. Enterocin B was found to be a heatstable bacteriocin, and samples of the purified bacteriocin diluted in MRS retained 25% of their activity after incubation at 100 "C for 20 min.
Analysis of the gene encoding enterocin B
Primers based on the partial amino acid sequence of enterocin B were constructed and PCR was used to obtain the DNA sequence of the region encoding enterocin B. Fig. 1 shows the DNA sequence of 353 contiguous nucleotides. Only one open reading frame, entB, was found in this sequence. The DNA sequencing confirmed the results of the amino acid sequencing and revealed that the bacteriocin is translated as a prebacteriocin of 71 aa which is then processed to give a mature enterocin B of 53 aa. The 18 aa N-terminal extension contains all the consensus elements of a leader peptide of the double-glycine type (Hharstein et al., 1994) . Downstream of entB, two 15 bp inverted repeats separated by 5 bp can establish a stable stem-loop structure with an estimated AG of -19.8 kcal mol-l ( -82.8 kJ mol-l). This structure is followed by several T residues and may serve as a rho-independent transcription terminator (Platt, 1986) .
The calculated molecular mass of the 53 aa peptide was 5465.2 Da and the PI was 9.49. The extinction coefficient at 280 nm was estimated as 7210 M-l cm-l.
A search for similarity in the nucleotide databases revealed one bacteriocin with strong sequence similarity to enterocin B, carnobacteriocin A (Worobo et al., 1994) , which is identical to piscicolin 61 (Holck et al., 1994) . Enterocin B and carnobacteriocin A have been aligned in Fig. 2 . Both bacteriocins are composed of 53 aa and are 47% identical at the amino acid level. Their leader peptides both contain 18 residues and share 72 % identity.
Inhibitory spectra of enterocins A and B
The sensitivity to purified enterocin A and enterocin B of a number of organisms was investigated by a critical dilution assay. Enterocins A and B ' Growth media for indicator species : lactic acid bacteria strains, MRS medium (Difco) ; Clostridium strains, RCM (Oxoid); Propionibacterium spp., GYE medium (Cintas et al., 1995) ; other strains, BHI medium (Oxoid). t Source abbreviations: ATTC, American Type Culture Collection (Rockville, MD, USA) ; CECT, Coleccion Espafiola de Cultivos Tip0 (Valencia, Spain) ; NCDO and NCFB, National Collection of Food Bacteria (Reading, UK) ; NCTC, National Collection of Type Cultures (London, UK) ; TNO, Nutrition and Food Research (Zeist, The Netherlands) ; FVM, Facultad de Veterinaria (Madrid, Spain); FRI, Food Research Institute (Madison, WI, USA). strains (Fig. 3) . Despite this, a low number of cells survived and were able to grow in the presence of either bacteriocin. However, mutants resistant to one of the two bacteriocins were still sensitive to the other (results not shown). We compared the bactericidal effect of enterocins A and B and mixtures of them. The number of survivors was drastically reduced in cultures treated with both bacteriocins compared to cultures exposed to only enterocin A or B, demonstrating a synergistic effect between the two bacteriocins. In the experiments described in Fig. 3, no survival was observed when a mixture of enterocins A and B was used.
DISCUSSION
During the last few years, a large number of bacteriocins from lactic acid bacteria have been described at the molecular level (Klaenhammer, 1993) . Most are small (2-5-6 kDa), thermostable, hydrophobic and cationic peptides, and enterocin B falls into this category. Our results indicate that enterocin B does not contain modified amino acids. The molecular mass found by mass spectrometry was 14 Da higher than that calculated from the amino acid sequence. This difference can be ascribed to oxidation of the only methionine residue in the bacteriocin and the formation of a disulfide bridge between its two cysteine residues. These modifications are formed spontaneously and have also been observed with synthetic peptide bacteriocins (Fimland et al., 1996) . When assayed in the presence of 5 mM dithiothreitol to reduce disulfide bridges, the titre of enterocin B was half of that found in the absence of the thiol compound (results not shown). This finding supports the idea of a disulfide bridge between Cys-23 and Cys-52 in enterocin B. Similar experiments have been done with pediocin PA-1 (Chikindas et al., 1993) (Hivarstein et al., 1994) . In both these cases, the activity was decreased when the Cys residues were in the reduced state.
Despite their physico-chemical similarities, there is a remarkable lack of sequence similarity among most of the bacteriocins from lactic acid bacteria (Klaenhammer, 1993) . The pediocin family is the only grouping that has been identified by sequence similarities, and bacteriocins of this family all contain the motif YGNGVxC in the Nterminal part (Lozano et al., 1992; Aymerich et al., 1996) . Enterocin B does not contain this motif. However, homology was found to carnobacteriocin A (Worobo et al., 1994) , also described as piscicolin 61 (Holck et al., 1994) . Enterocin B and carnobacteriocin A are 47% identical. T o our knowledge, this is the first report on two non-lantibiotic bacteriocins from lactic acid bac-teria with strong sequence similarity outside the pediocin family of bacteriocins.
The gene encoding bacteriocin immunity is usually located immediately downstream of, and in the same operon as, the structural gene for non-lantibiotics of lactic acid bacteria. Enterocin B and carnobacteriocin A are exceptions to this rule. In both cases, the bacteriocin gene is followed by a putative rho-independent terminator. Genes encoding immunity to enterocin B or carnobacteriocin A have not been identified, but according to Worobo et al. (1994) the genes for carnobacteriocin A production and immunity are located on the same 5-4 kb restriction fragment of the bacteriocin plasmid.
Despite the absence of the YGNGVxC motif, enterocin B shares sequence similarities with members of the pediocin family. Its 18 aa leader peptide has the same size as, and 50 % or more sequence identity to, the leader peptide of carnobacteriocin A and most members of the pediocin family (Fig. 2) . Furthermore, the 16 C-terminal amino acids of pediocin PA-1 are 42% identical (54% similar) to the corresponding residues in enterocin B.
The sequence alignment of the prepeptides of enterocin B, carnobacteriocin A and pediocin-like bacteriocins revealed that consensus residues, including a GWAxG motif, are shared between the two groups of bacteriocins in their C-terminal parts.
It is tempting to speculate that the conserved residues in the C-terminal region reflect structure-function relationships. Fimland et al. (1996) showed that the C-terminal part of the pediocin-like bacteriocins is of importance for their activity. It is interesting to note that leucocin A-UAL 87, which lacks some of the consensus residues in the C-terminal part of the molecule, has bacteriostatic but no bactericidal activity (Stiles, 1994) .
Enterocins A and B both have broad and very similar inhibitory spectra. From an applied point of view, it is interesting that both are able to inhibit food-borne and pathogenic species like List. monocytogenes, C. tyrobutyricurn and S. aureus. Since enterocin B was inhibitory to a few strains that were insensitive to enterocin A, we hypothesized that the two bacteriocins could have differences in their mode of action and therefore may act synergistically. Two assays were used to test for synergism. In the critical dilution assay, the bacteriocin concentration causing 50 % growth inhibition can be determined, but the level of inhibition at other bacteriocin concentrations is not determined. No synergism between enterocins A and B was observed in this assay. Because the bactericidal effect of neither bacteriocin was complete, we could investigate synergism at higher bacteriocin concentrations by measuring the survival of cells exposed to the bacteriocins. At concentrations at which most of the cells were killed, the synergistic bactericidal effects of enterocins A and B were clearly demonstrated, and the number of survivors was reduced by several orders of magnitude when a mixture of the two bacteriocins was used.
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Enterocins A and B Typically, a 3 4 log reduction in c.f.u. is obtained by exposing a sensitive culture t o pediocin-like bacteriocins (Chikindas et al., 1993 ; Rekhif et al., 1994; Schillinger et al., 1991) . The survivors from exposure to high concentrations of bacteriocins belonging to the pediocin family remain resistant to the bacteriocin (Rekhif et al.,  1994) , but the survivors of exposure to enterocin A had not acquired resistance to enterocin B (results not shown). Thus a likely explanation of the reduced survival obtained by exposing a culture to both bacteriocins is that enterocin B is able to kill the bacteria that survive enterocin A treatment.
Our findings may be important from an applied point of view. In food preservation, the combined use of enterocin A and enterocin B is likely to be better than using a pediocin-like bacteriocin alone to prevent growth of spoilage bacteria. As a starter culture for food fermentation, E . faecium T136 has the advantage that it produces both these bacteriocins.
